EQS-News: SARTORIUS AG / Key word (s): Annual Results/Quarter Results Sartorius closes fiscal 2024 with very good fourth quarter and positive trend; full-year guidance achieved (news with ...

They display data obtained by flow cytometry, a method for analyzing hundreds of thousands of individual cells based on their shape, consistency and other features. Once the domain of ...

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...

To support physicians in treating cancer patients, oncology laboratories can benefit from adopting end-to-end automation of flow cytometry workflows. Rapid advances in automation are improving ...

Rad's challenges in the life sciences tools market, cautious approach, R&D spending, stake in Sartorius, and growth potential ...

The Flow Core Currently has a BD FacsVantage equipped with 5 lasers and 8 detectors as well as an Accuri Flow Cytometer Analyzer Connected to an Intellicyt Hypercyt robotic system cappable of running ...

Flow price prediction for 2025 could reach a maximum value of $1.37. By 2028, FLOW could reach a maximum price of $4.13. In 2031, FLOW will range between $10.63 to $12.56. Flow coin, the native token ...

DIM.PA Sartorius Stedim Biotech S.A.